Bokf, Na Abbott Laboratories Transaction History

Bokf, Na

$5.65 Billion
Q3 2024

A detailed history of Bokf, Na transactions in Abbott Laboratories stock. As of the latest transaction made, Bokf, Na holds 138,853 shares of ABT stock, worth $16.4 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

138,853

Previous 126,085 10.13%

Holding current value

$16.4 Million

Previous $13.1 Million 20.83%

% of portfolio

0.28%

Previous 0.24%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $1.28 Million - $1.51 Million	12,768 Added 10.13%	138,853 $15.8 Million
Q2 2024 Aug 07, 2024	SELL	$100.73 - $112.44 $2.03 Million - $2.26 Million	-20,131 Reduced 13.77%	126,085 $13.1 Million
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $1.77 Million - $1.96 Million	-16,167 Reduced 9.96%	146,216 $16.6 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $484,410 - $592,958	-5,371 Reduced 3.2%	162,383 $17.9 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $2.27 Million - $2.72 Million	-23,761 Reduced 12.41%	167,754 $16.2 Million
Q2 2023 Aug 21, 2023	BUY	$100.78 - $112.29 $366,133 - $407,949	3,633 Added 1.93%	191,515 $20.9 Million
Q1 2023 May 11, 2023	SELL	$96.86 - $114.01 $2.53 Million - $2.98 Million	-26,141 Reduced 12.21%	187,882 $19 Million
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $2.01 Million - $2.35 Million	-21,116 Reduced 8.98%	214,023 $23.5 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $7.06 Million - $8.18 Million	-73,000 Reduced 23.69%	235,139 $22.8 Million
Q2 2022 Aug 11, 2022	SELL	$102.07 - $123.37 $366,533 - $443,021	-3,591 Reduced 1.15%	308,139 $33.5 Million
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $461,438 - $562,694	4,047 Added 1.32%	311,730 $36.9 Million
Q4 2021 Mar 11, 2022	SELL	$115.53 - $141.46 $32.4 Million - $39.7 Million	-280,404 Reduced 47.68%	307,683 $43.3 Million
Q3 2021 Nov 10, 2021	SELL	$116.66 - $129.06 $49 Million - $54.2 Million	-420,192 Reduced 41.67%	588,087 $69.5 Million
Q1 2021 Apr 21, 2021	SELL	$108.84 - $128.23 $2.05 Million - $2.42 Million	-18,857 Reduced 1.84%	1,008,279 $121 Million
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $82.8 Million - $90.2 Million	788,429 Added 330.29%	1,027,136 $112 Million
Q3 2020 Oct 30, 2020	BUY	$91.64 - $111.29 $4.6 Million - $5.59 Million	50,226 Added 26.65%	238,707 $26 Million
Q2 2020 Aug 12, 2020	SELL	$76.57 - $98.0 $71,746 - $91,826	-937 Reduced 0.49%	188,481 $17.2 Million
Q1 2020 May 13, 2020	SELL	$62.82 - $91.86 $422,150 - $617,299	-6,720 Reduced 3.43%	189,418 $14.9 Million
Q4 2019 Feb 12, 2020	SELL	$78.51 - $87.4 $25,280 - $28,142	-322 Reduced 0.16%	196,138 $17 Million
Q3 2019 Nov 13, 2019	SELL	$81.84 - $88.74 $1.96 Million - $2.12 Million	-23,893 Reduced 10.84%	196,460 $16.4 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $652,859 - $761,430	8,958 Added 4.24%	220,353 $18.5 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $370,368 - $447,775	-5,593 Reduced 2.58%	211,395 $16.9 Million
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $939,147 - $1.06 Million	-14,325 Reduced 6.19%	216,988 $15.7 Million
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $2,493 - $3,007	-41 Reduced 0.02%	231,313 $17 Million
Q2 2018 Aug 13, 2018	SELL	$57.57 - $63.54 $517,669 - $571,351	-8,992 Reduced 3.74%	231,354 $14.1 Million
Q1 2018 May 14, 2018	BUY	$56.27 - $63.62 $140,224 - $158,541	2,492 Added 1.05%	240,346 $14.4 Million
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $2.59 Million - $2.77 Million	-48,216 Reduced 16.85%	237,854 $13.6 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $13.7 Million - $15.3 Million	286,070	286,070 $15.3 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

News

Stay updated on Bokf, Na with notifications on news.

Account